EIR Rubin, Mark, G., MD Mar 2014

James Fleckenstein FDA$595.00 - Available Now

FDA investigators audited the Rubin, Mark, G., MD - Beverly Hills, CA, United States facility and issued inspectional observation (via FDA 483) on 11 Mar 2014.

Product details

  • Category:
  • Inspection end: 11 Mar 2014
  • Location: Beverly Hills, United States
  • FEI: 3003826291
Add To Cart